The Outcomes Related to COVID-19 Treated with Hydroxychloroquine among In-patients with Symptomatic Disease (ORCHID) trial stopped enrolling new patients based on the fourth scheduled interim analysis showing no evidence of benefit or harm.
Dr. Jeff Balser talks about how VUMC has responded to the COVID pandemic, how our institution can help our region work toward a healthier and more just future, and how each of us at VUMC can make our voices heard as we build that future together.
The number of hospitalized COVID-19 patients reached its highest level to date on June 15, when more than 400 patients were hospitalized across Tennessee, according to a report from researchers at Vanderbilt.
Vanderbilt Institute for Global Health (VIGH) has received a new research training grant and a renewal for an existing training program from the Fogarty International Center (FIC) of the National Institutes of Health (NIH) to build HIV-focused research capacity with key partners in Nigeria and Mozambique.
Vanderbilt University Medical Center’s Division of Obstetric Anesthesiology has been designated as a Center of Excellence (COE) by the Society for Obstetric Anesthesia and Perinatology (SOAP).
Again this year, Vanderbilt University Medical Center has been named as one of Becker’s Healthcare “100 great hospitals in America.”